Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Kissei Pharmaceutical Co ( (JP:4547) ) is now available.
Kissei Pharmaceutical Co. has revised its financial forecast for the fiscal year ending March 31, 2026, due to a new technology licensing agreement that increases R&D expenses, impacting operating and ordinary profits. Despite this, the company expects to maintain its profit forecast by recording extraordinary income from the sale of investment securities, aimed at improving capital efficiency and funding growth investments.
The most recent analyst rating on (JP:4547) stock is a Hold with a Yen3600.00 price target. To see the full list of analyst forecasts on Kissei Pharmaceutical Co stock, see the JP:4547 Stock Forecast page.
More about Kissei Pharmaceutical Co
Kissei Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and commercialization of innovative drugs. The company emphasizes enhancing its research and development pipeline through strategic licensing agreements.
Average Trading Volume: 94,758
Technical Sentiment Signal: Buy
Current Market Cap: Yen176.9B
Find detailed analytics on 4547 stock on TipRanks’ Stock Analysis page.